Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Epitranscriptomics 2019

About Conference

ME Conferences Graciously invites all the members and attendees from all over the world to attend “International Conference on Epigenetics and Epitranscriptomics" during November 28-29, 2019 at Bucharest, Romania with the Theme: Novel Innovations and Techniques in Genetics for making Life Better which embraces prompt Keynote Presentations, Oral talks, Poster Presentations, Workshop, Symposia and Demonstrations.

Epitranscriptomics 2019 is a relatively new field in the world of genetics and a brand new look at the RNA field of Genetics and Molecular Biology which studies the structure and function of genes at a molecular level. The consider of chromosomes and quality expression of a life form can provide knowledge into heredity, hereditary mutation, and changes. This is valuable to study the developmental biology and treating the hereditary diseases which is all about simplifying the complex phenomenon behind Epigenetic mechanism & protein expression. The capacity to get a large picture of sickness transcriptomes & how it gives a clear understanding of the principal genome which is changed over into the valuable quality calming classification, assurance and individualized treatment.

Why to Attend?

Epitranscriptomics Conference is a novel discourse to join together in general recognized scholastics in the field of Hereditary qualities and atomic science Analysts, Open prosperity specialists, Researchers, Scholastic analysts, Industry masters, Researchers to exchange almost condition of the Investigate and Advancement.

Point of this gathering is to fortify new views for treatment that will be valuable over the range of Epitranscriptomics. Importantly, mutations in core-regulators of the epitranscriptomes are causative in many human diseases or congenital disorders. It is also a great opportunity to intermingle with members across the world and form molecular level with related associations and societies.

Target Audience:

Our organization takes immense pleasure in welcoming,

·         Scientists

·         Epigenetics, Genetics and Oncology Researchers

·         Human Genetics / Epigenetics / Cancer Associations and Society

·         Molecular Biologists

·         Business delegates

·         Directors, Board Members, Presidents, Vice Presidents

·         Cell Biologists

·         CEO's and R&D Heads from Industries

·         Business Entrepreneurs and Industrialists

·         Human Genetics Researchers

·         Pharmacists

·         Drug Manufacturing Companies and Industries

·         Laboratory Technicians and Diagnostic Company


All accepted abstracts will be published in the supporting journals of the conference and Conference Book Proceeding.

Each abstract will receive a DOI number provided by Crossref.

Opportunity to conduct Workshop with your team members.

Opportunity to chair a session.

Certification by the organizing committee.

Individual keynote Page will be created to get more visibility for your scientific research.

Huge Benefits on Group Registration and much more.


1. Cancer Epigenetics

Cancer is caused by failure of checks and balances that control cell numbers in response to the needs of the whole organism. Inappropriate function of genes that promote or inhibit cell growth or survival can be caused by errors introduced into the genetic code itself or by faulty epigenetic mechanisms deciding which genes can and cannot be expressed. Two of the main methods are DNA methylation and histone modification. Methylation involves tacking a methyl group onto DNA. Epigenetic gene regulation collaborates with genetic alterations in cancer development. This is evident from every aspect of tumor biology including cell growth and differentiation, cell cycle control, DNA repair, angiogenesis, migration, and evasion of host immunosurveillance.

Sub Tracks

  • Cervical Cancer

  • Rhabdoid Tumor

  • Prostate Cancer

  • Brest Cancer

  • Chromatin dysregulation

2. Clinical Epigenetics

The study of epigenetic principles and mechanisms as applied to human development, disease, diagnosis and treatment. Clinical epigenetics is being incorporated into patient management in oncology, as well as being explored for clinical applicability for other human pathologies such as neurological and infectious diseases and immune system disorders.

Sub Tracks

  • Cancer        

  • Aging

  • Neurological disease

  • Immune disorders

  • Viral infections

 3. Genomes and Epigenomes

Epigenomes are made up of some chemical compounds and proteins which will attribute some genes and DNA that monitoring the production of proteins in a particular cell. The epigenomes have many alterations to the genome and some specialized cell that makes protein. The chemical modifications of epigenomes to the DNA and DNA-associated proteins in the cell, which alter gene expression, are heritable. The variations occur as a tissue development and differentiation that can be altered in response to environmental exposures and diseases. The epigenome has immediate applications for diagnostics. Changes to the epigenome can result in changes to the structure of chromatin and changes to the function of the genome.

Sub Tracks

  • Human Genome

  • Human Genomics Project

  • Plant Genomics

  • Histone Modification Assay

  • Epigenomics Compounds

  • Epigenetics variation

4. Epigenetics in Cardiovascular Disease

The DNA methylation, post-translational histone modifications, and microRNA regulation are key mechanisms underlying healthy cardiovascular function as well as heart disease and its precursors. There is increasing evidence for the involvement of epigenetics in human diseases such as cancer, inflammatory disease, and CV disease. Other chronic diseases are also susceptible to epigenetic modification such as metabolic diseases including obesity, metabolic syndrome, and diabetes mellitus. There is much evidence for the modification of epigenetics by nutrition and exercise. Epigenetics are also involved in cardiovascular risk factors such as smoking, diabetes and hypertension. Gene expression regulation through the interplay of DNA methylation and histone modifications is well-established, although the knowledge about the function of epigenetic signatures in cardiovascular disease is still largely unexplored.

Sub Tracks

  • Cardiomyopathy                         

  • Hypertensive heart disease                     

  • Heart failure                                

  • Congenital heart disease             

  • Rheumatic heart disease             

  • Pulmonary heart disease

 5. Epigenetics Biomarkers

Epigenetic biomarkers defined as the modifications of the genome with preserved DNA sequence. DNA methylation measurement in cell, it may also be useful in improving early detection by measuring tumor DNA released into the blood. Molecular biomarkers are used routinely in a clinical setting to assess the medical state of patients and in several other medical contexts, including clinical trial endpoints, pharmaceutical development, and basic science research. The clinical validation of epigenetic biomarkers to allow the accurate prediction of the outcome of cancer patients and their potential chemo sensitivity to current pharmacological treatments. A clinical example of a biomarker is plasma glucose.

Sub Tracks

  • Testis Cancers

  • Urological Cancers

  • Genetic Biomarkers

  • Biomarkers for lung cancer

  • Breast Cancer

  • Ovarian Cancer     

  • Malignant rhabdoid Tumors

6. Stem cells and Epigenetics

The epigenetic basis of stem cell differentiation arises from the need to maintain gene expression patterns in both stem/progenitor cells and their differentiated progenies. As a stem cell differentiates, genes associated with self-renewal are down-regulated, while lineage-specific genes are activated. Chromatin modifying enzymes with opposing activities play a key role in the dynamic regulation of epigenetic marks. Defining the signalling pathways of these enzymes induced by differentiation-inducing cues is critical to understanding the mechanisms underlying stem cell differentiation. Furthermore, non-coding RNAs, especially microRNAs, provide additional layers for regulation of gene expression during cell fate specification. These multiple layers of regulation allow for rapid transition of proliferating stem cells into their differentiated progenies.

Sub Tracks

  • Neural Stem Cells (NSCs)

  • Mesenchymal Stem Cells (MSCs)

  • Induced Pluripotent Stem Cells (iPSCs)

  • Huntington’s disease

  • Alzheimer’s disease

7. Plant Epigenetics

Epigenetic component makes a difference to ensure the plant cells from the action of parasitic groupings such as transposable components, this defense can complicate the hereditary designing prepare through transcriptional quality silencing. The frequently occurring changes in plants which incorporates heritable or metastable changes causing varieties in epigenetic status. Hence, heritable epigenetic varieties as well as hereditary variety have the potential to drive common varieties in plants. Climate alter is without a doubt one of the most prominent dangers confronting both plants and creatures alike. With rising temperatures and irregular climate designs, dry spells have gotten to be a distant as well typical event worldwide.

Sub Tracks

  • Heritability of Epigenetic Marks                          

  • DNA Methylation in Plants                                

  • Crop epigenetics: Hybridization and Heterosis                            

  • Natural variation and Ecological Epigenetics                  

  • Stress-induced Epigenetics Changes                    

  • Epigenetics Regulation of host-pathogen interactions

8. Animal Epigenetics

Epigenetic mechanisms can also be caused by environmental factors, such as diet, stress, exposure to toxic products, etc., and not merely the chance of genetic mutations. Epigenetic mechanisms governing animal phenotype and behavior. Epigenetic parameters orchestrating transgenerational effects, as well as hereditary disorders, and the often-overlooked areas of livestock immunity. Epigenetics has the potential to be very useful in animal breeding, as it may provide information relating to the heritability of complex traits and diseases.

Sub Tracks

  • Animal Models in Epigenetics Research

  • Animal Epigenetics Welfare

  • Animal Cloning Epigenetics

  • Genome Instability

  • Non-coding RNAs

9. Chromatin and chromosome dynamics

Chromatin is a complex of DNA, RNA, and protein which packages very long DNA molecules into a more compact, denser shape, preventing the strands from becoming tangled, preventing DNA damage, and regulating gene expression and DNA replication. Chromosome mechanisms during replication and in response to DNA damage, ensuring the faithful inheritance of genetic and epigenetic information and maintaining genome stability. Epigenetic modification of the structural proteins in chromatin via methylation and acetylation also alters local chromatin structure and thus gene expression. The structure of chromatin networks is currently poorly understood and hence is an active area of research in molecular biology.

Sub Tracks             

  • Sexual Chromosomes

  • Autosomal Chromosomes

  • Homo and Hetero Chromosome

  • Euchromatin

  • Nuclear Architecture

10. Epitranscriptomics

Epitranscriptomics can be defined as a functionally relevant change to the transcriptome that do not involve a change in the ribonucleotide sequence. The epitranscriptome, therefore, is defined as the study of posttranscriptional changes with vigor in both protein-coding and non-coding RNAs reveals a new complexity in gene regulation. Thus leading to 'Epitranscriptomics', organized with bioinformatics approaches and RNA modifications.T here are a few sorts of RNA alterations that affect quality expression. These adjustments happen to all sorts of cellular RNA counting, but not constrained to, ribosomal RNA (rRNA), Transfer ribonucleic acid RNA (tRNA), Messenger RNA (mRNA), and little atomic RNA (snRNA). The most collective and well-understood mRNA alteration at show is the N6-Methyladenosine (m6A), which has been inspected to happen an normal of three times in each mRNA methylation.

Sub Tracks

  • Chromatin Modifications

  • Genomic Imprinting

  • mRNA Methylation

  • miRNAs

  • RNA Editing                                                                                      

  • RNA Modification Mapping                               

  • RNA Modification in Disease

11. Epigenetics in Rare Diseases

Rare hereditary recessive diseases were thought to be expressed in off-spring only when both parents carry a mutation in the causal gene. A rare disease is any condition that affects a small percentage of the population. Some rare diseases have an epigenetic component or involve epigenetically regulated genes. While genetic mutations are very rare, epigenetic changes are common and occur through our lifetimes. Therefore, when discussing the etiologic factors in some rare diseases.

Sub Tracks

  • Rubinstein-Tabi Syndrome (RTS)

  • Rett Syndrome (RTT)

  • Instability Facial Syndrome 1 (ICF1)

  • Sotos Syndrome

12. Translational Epigenetics

The emerging promise of translational epigenetics is highlighted in a range of stimulating clinical experiments underway on epigenetic pathways which offer new therapeutic approaches to cancer. Epigenetic modifications such as DNA methylation, histone modifications and nucleosome remodelling have been found to be diagnostic hallmarks in a range of human tumors. The pathways which are regulated (or mis regulated) via histone modifications, DNA methylation and other epigenetic marks are being investigated as potential targets of such epi-drugs.

Sub Tracks                      

  • Controlling Gene expression   

  • Stem or Progenitor cells                                   

  • Neoplastic Transformations                     

  • Post-translational Modifications              

  • Histone Variants

13. Genes and Environment

The Identification of epigenetic occasions discharged by particular natural and presence stressors and these discoveries proceed to amplify our understanding of the mechanism of carcinogenesis, particularly those linked to risk-factor exposures and aging. In addition, important insights into epigenetic mechanisms and associated exposure risk factors have had a functional impact of specific human cancers. Environmental contaminants are linked to impacts on human health and consequences of combustion to contaminating trace metals and residual organic compounds used in daily life.

Sub Tracks                         

  • Epigenetic Effects of Air pollutant exposure 

  • Carcinogen Evaluation                                 

  • Ecological Epigenetics                             

  • Infections and Microbiome                                 

  • Early Life exposures

14. Gene Editing and CRISPR Based Technologies

Genome editing is of great interest in the prevention and treatment of human diseases. Currently, most research on genome editing is done to understand diseases using cells and animal models. Ethical concerns arise when genome editing, using technologies such as CRISPR-Cas9, is used to alter human genomes. Most of the changes introduced with genome editing are limited to somatic cells, which are cells other than egg and sperm cells. These changes affect only certain tissues and are not passed from one generation to the next. However, changes made to genes in egg or sperm cells (germline cells) or in the genes of an embryo could be passed to future generations.

Sub Tracks

  • Genome Engineering

  • RNA editing

  • Disease models

  • CRISPR in Cancer

15. Epigenetics in Reproductive Health

Epigenetic changes are believed to be a result of changes in an organism's environment that result in fixed and permanent changes in most differentiated cells. Some environmental changes that have been linked to epigenetic changes include starvation, folic acid, and various chemical exposures. There are periods in an organism's life cycle in which the organism is particularly susceptible to epigenetic influences; these include fertilization, gametogenesis, and early embryo development. Epigenetic influences might be involved in the regulation of foetal development and the pathophysiology of adult diseases such as cancer, diabetes, obesity, and neurodevelopmental disorders. Various epigenetic mechanisms may also be involved in the pathogenesis of preeclampsia and intrauterine growth restriction. Additionally, environmental exposures are being held responsible for causing epigenetic changes that lead to a disease process.

Sub Tracks

  • Histone code

  • Epigenomics

  • MicroRNAs

  • Epigenetic marks

  • DNA Methylations

16. Pharmacogenomics and Personalized Medicine

The practices of personalized medicine are to maximize the therapeutic effects of likelihood and to minimize the risk of drug toxicity for an individual patient. Pharmacogenomics is the study of the genome in drug response. The genetic disorder occurrence is quite rare in population; some might be hereditary while the others are caused by mutations. Disease-specific epigenetic signatures such as DNA methylation, hydroxymethylation, and non-coding RNAs are now being utilized clinically for prognostics and diagnostics, while an expanding collection of genetically aberrant, abnormally expressed or chromatin-interacting epigenetic enzymes are positioned as promising targets for therapeutic intervention. Scientists also recognize that even as the knowledge base continues to expand, the clinical translation of that knowledge still requires empirical evidence, generated for a particular disease and drug combination, before treatment can be customized to a patient's genotype.

Sub Tracks                         

  • Genomic DNA and mRNA

  • Serotonin transporter gene 

17. Epigenetics Therapy

Epigenetic therapy is a relatively new treatment that is related to gene therapy, as the treatment looks at changes in the DNA. However, unlike gene therapy, which works to alter the DNA sequence, epigenetic therapy focuses on changes in DNA expression. Epigenetic drugs for cancer treatment have opened the door for the development of epigenetic drugs for other disorders including neurodegenerative diseases. The understanding of the contribution of epigenetic changes to rare diseases provides useful principles for other common and complex disorders such as cancer, cardiovascular, type 2 diabetes, obesity, and neurological diseases and will hopefully provide us with better molecular tools for an improved diagnosis, prognosis, and therapy for the patients in the future.

Sub Tracks

  • p53 Gene Therapy

  • Immunotherapy

  • Histone Deacetylase Inhibitors

  • DNA Methyltransferase Inhibitors

  • miRNA Biomarkers and Interventions

18. Current Case studies in Epigenetics and Epitranscriptomics

It is the knowledge of epigenetics, combined with rising of technologies such as CRISPR/Cas9 gene editing and next-generation sequencing. In recent years, it permits us to superior recognize the interaction between epigenetic alter, quality direction, and human diseases, and will lead to the improvement of unused approaches for atomic determination and focused on molecular medicines over the clinical range. Recent technical advances such as ChIP-on-ChIP and ChIP-seq have started to convert epigenetic research. The advance knowledge in the field is to understand the basic biology and human diseases, the catalyzing adoption of epigenetics or epitranscriptomics methods. Finally, the advancement of current approaches, coupled with new technologies, will allow for the development of new therapies and therapeutic targets for human diseases associated with deficient RNA modifications.

Sub Tracks

  • Combating Diseases with Epigenetics Therapy                    

  • Epigenetics and Ethics                                  

  • New Epigenetic Phenomena              

  • Epigenetics Yoga Therapy                              

  • Case reports on Molecular Biomarkers

Related Associations or Societies:


American Society of Human Genetics (ASHG), National Society of Genetic Counsellors (NSGC), American College of Medical Genetics (ACMG), American Board of Genetic Counselling (ABGC), American Board of Medical Genetics (ABMG), Nation Coalition for Health Education in Genetics (NCHPEG), International Society of Nurses in Genetics (ISONG), Council of Regional Networks (CORN) discontinuedCanadian College of Medical GeneticistsCollege Canadian de Généticiens Médicaux (CCMG), Canadian Collaborative Group for Cancer Genetics (CCGCG), European Genetics Foundation (EGF)Clinical Molecular Genetics Society (CMGS) United KingdomThe American Public Health AssociationNational Society of Genetic CounselorsInternational Mammalian Genome Society, British Society of Genetic MedicineInternational Federation of Human Genetics SocietiesGenetics society of America


European Society Of Human GeneticsAmerican Society of Human Genetics  ,German Genetics SocietyInternational Society of Genetic GenealogyThe American Society of HaematologyASGCT  American Society of Gene & Cell TherapyInternational Society of Genetic GenealogyAustrian Society for Human GeneticsBelgian Society for Human GeneticsCzech Society of Medical GeneticsDanish Society of Medical Genetics

Asia-Pacific and Middle East

East Asian Union of Human Genetics Societies, Association of Chinese Geneticists in AmericaHong Kong Society of Medical GeneticsJapan Society of Human GeneticsGenetics Society of Korea (GSK), Korean Society of Human GeneticsGenetics Society of VietnamTurkish Association of Medical GeneticsJapan Society of Gene TherapyHuman Genetics Society of Australasia (HGSA), Australian Society of Genetic Counsellors ,Genetic Society of Australia (GSA),American Human Geneticists of Indian Subcontinent OriginIndian Society of Human GeneticsNational Laboratory for the Genetics of Israeli PopulationsIsraeli Society of Medical GeneticistsMiddle East Genetics Association.


Related Conferences:

Epigenetics Conferences | Genetics Congress | Biotechnology Meetings |

Molecular Biology Conference

International Epigenetics and Epitranscriptomics Conference, November 26-27, 2018 Helsinki, Finland | 11th Regenerative Medicine Congress July 19-20, 2018, Dubai, UAE | Chromatin, Epigenetics & Transcription, Suzhou, China, April 16-20, 2018 | 5th World Congress on Epigenetics and Chromosome, October 25-26, 2018, Istanbul, Turkey | 4th International Congress on Epigenetics & Chromatin September 03-05, 2018 London, UK | 11th World Congress and Expo on Cell & Stem Cell Research March 18-19, 2019 Chicago, Illinois, USA | 6th Global Summit on Plant Science, October 29-30, 2018 Valencia, Spain | International Conference on Obesity and Diet Imbalance, November 29-30, 2018 Bali, Indonesia  | 8th World Conference on Women’s Health and Breast Cancer, December 17-18, 2018, Abu Dhabi, UAE | 32nd Euro Congress on Cancer Science & Therapy,  March 07-08, 2019,  Barcelona, Spain  | 2nd World Conference on Medical Oncology Haematology, Mar 27-28, 2019, Hong Kong | 2nd Global Meeting on Clinical Oncology and Radiology, Mar 27-28, 2019, Hong Kong |  Epigenetics in the nervous system: development and disease,  1 - 3 October, 2018, Stockholm, Sweden | 3rd Molecular Diagnostics Conference April 19-20, 2018, Dubai, UAE | 2nd Cell Metabolism Summit September 19-20, 2018, Philadelphia, USA | 3rd Stem Cell Conference, July 19-20, 2018, Dubai, UAE |   Epigenetics & Chromatin - New York, US - 11–15 Sept 2018 Conference |  ICECT 2018 : 20th International Conference on Epigenetics, Chromatin and Transcription - Osaka, Japan - 13– 14 Sept 2018 Conference  | The 5th Canadian Conference on Epigenetics - Quebec, Canada -  30–03 Oct 2018 Conference | 



Market Analysis

Scope: The Scope of the conference is to gather all the Physicians, Researchers, Business Delegates and Scientists to approach and deliver all the attendees about the latest scientific advancements on the particular sphere of influence. This Epigenetics and Epitranscriptomics Conference is the premier event focusing on understanding in individual and organizational behaviour and decision-making related to genetics and molecular biology, biotechnology, pharmaceuticals, medicals, and academia.

Importance:  Conference on Epitranscriptomics 2019 is a much-celebrated conference which basically deals with the latest research and developments in the sphere of genetics and molecular biology .This Conference will give a culminate stage to all the worldwide blend of driving Investigate researchers, and researchers accomplished significance in their field of think about, investigate academicians from the colleges and investigate teach, mechanical inquire about experts and trade partners along with Ph.D.


The conference discusses the latest research outcomes and technological advancements in the field of genetics and molecular biology.

•              Scientists

•              Epigenetics, Genetics and Oncology Researchers

•              Human Genetics/ Epigenetics/Cancer Associations and Society

•              Molecular Biologists

•              Business delegates

•              Directors, Board Members, Presidents, Vice Presidents

•              Cell Biologists

•              CEO's and R&D Heads from Industries

•              Business Entrepreneurs and Industrialists

•              Human Genetics Researchers

•              Pharmacists

•              Drug Manufacturing Companies and Industries

•              Laboratory Technicians and Diagnostic Companies


Today’s Market Study of Epitranscriptomics research in USA | Europe | Middle East | Asia Pacific

Asia Pacific: The Europe genetic testing market is valued at USD 1.20 billion in 2016, and is projected to reach USD 1.6 billion by 2021, growing with a compound annual growth rate (CAGR) of 8.2% during the forecast period, 2016-2020.

USA: The USA Genetics market is poised to reach USD 19.99 Billion by 2020, growing at a CAGR of 9.9% during the forecast period from 2015 to 2020.

Europe: The global Epigenetic value on the market was estimated $419.4 million in 2013 and is expected to grow at a CAGR of 13.9% in the next five years.

Middle East: The global gene expression analysis market is projected to reach USD 5.30 Billion by 2020 from USD 3.39 Billion in 2015, at a CAGR of 9.3% from 2015 to 2020. The primary growth appliance in this region is China, which is expected to record a growth rate of 12.5% in the forecast period.

The falling sequencing expenses and time increase in research activities to identify and progress inhibitors/drugs for various diseases, funding for epigenetics research, and rising the prevention of cancer are the major factors driving the progression of this market.

The global market for Epigenetic Testing is forecast to reach US$2.4 billion by 2019. Increasing knowledge about the potential benefits in Epigenetic testing is one of the prime reasons for the growth of the genetic analysis. Developments in the genetic modifications space, aging population and a consequent rise in the number of genetic diseases, and increasing incidence of cancer cases are the other factors impelling growth in the genetic testing market.

Global Epigenetics Market, by Research Areas

Developmental Biology

Drug Discovery


Other Epigenetics Research Areas


The glance at the Market

Some key players of the epigenetics market incorporate, Abcam, Illumina, Diagenode, Thermo Fisher Scientific, Merck, Zymo research, Qiagen, CellCentric Ltd, Chroma Therapeutics Ltd, Eisai Co. Ltd, Novartis International AG., Syndax Pharmaceuticals, Inc., Valirx Plc and Sigma-Aldrich Corporation, Oncolys Biopharma Inc.

Extensive R&D activities went for the advancement of novel medications and the nearness of solid item pipeline is relied upon to further help market development over the gauge time frame. Grand View Research has fragmented the global epigenetics market on the basis of product, technology, application and region:

Epigenetics Product Outlook (Revenue, USD Million, 2015 – 2022)





Epigenetics Technology Outlook (Revenue, USD Million, 2015 – 2022)

DNA Methylation

Histone Methylation

Histone Acetylation

Large noncoding RNA

MicroRNA Modification

Chromatin structures


Epigenetics Application Outlook (Revenue, USD Million, 2015 – 2022)


Solid Tumors

Liquid Tumors


Inflammatory Diseases

Metabolic Diseases

Infectious Diseases

Cardiovascular Diseases


Epigenetics Market Regional Outlook (Revenue, USD Million, 2015 – 2022)

North America






Asia Pacific




Latin America



Middle East and Africa (MEA)

South Africa


Why it’s in Helsinki?

Helsinki is the capital of Finland, vibrant seaside of attractive islands and prodigious green parks. Helsinki’s is been awarded with City of Design status by UNESCO. The population of 1.4 million makes it the most populous metropolis and urban area in Finland with important political, educational, financial, cultural and research centre. The capital of Finland is filled with lively events all year round. Design Scene, Architectural Innovations, Finnish Flavours, Natural Environment add colors to Helsinki.

Scientists in Finland are working on making stem cells as key to youth. Stem cell research is widely recognised and funded in European Countries where researchers doing great work on stem cell and regenerative medicine.  In fact, ensuring the principle that stem cell research provides vast perspective to create new treatments for several serious diseases such as diabetes and heart disease. The location of the Helsinki Airport is the neighbouring city of Vantaa, which has frequent service to many destinations in Europe and Asia. Helsinki was the World Design Capital for 2012.

List of universities around the globe:

University of Oxford

University of Washington

Stanford University

University of Tokyo

University of Cambridge

Icahn School of Medicine at Mount Sinai

University of Queensland Australia

McGill University

University of British Columbia

Aix-Marseille Universities

Karolinska Institute

University of Helsinki

London School of Hygiene & Tropical Medicine

University of Chicago

Top universities in Finland:

University of Helsinki

University of Tampere

Abo Akademi University

University of Oulu

University of Eastern Finland

University of Jyväskylä

Tampere University of Technology

University of Turku

Aalto University

Lappeenranta University of Technology

Top Universities in Helsinki

University of Helsinki

Metropolia University of Applied Sciences

Haaga-Helia University of Applied Sciences

Arcada University of Applied Sciences

HUMAK University of Applied Sciences

Diaconia University of Applied Sciences


Past Conference Report

Epitranscriptomics 2018

Conference Series LLC successfully hosted its premier International Epigenetics and Epitranscriptomics Conference during November 26-27, 2018 in Helsinki, Finland.

The conference brought together an extensive range of the epigenetics education community, educators from research universities as well as representatives from industry and professional genetics societies. Conference Series LLC wishes to acknowledge with its deep sincere gratitude to all the supporters from the Editorial Board Members of our Open Access Journals, Keynote speakers, valuable speakers, delegates and for their support to make this event a huge success.


This International Epigenetics and Epitranscriptomics Conference was based on the theme “The Evolving Landscape of Epigenetic Research” which covered the scientific sessions like Cancer Epigenetics, Molecular Pathology, Cytopathology, Histopathology & Immunopathology, Genetic Diseases, Dermatopathology & Dermatological Infections, Molecular Genetic, Microbial Forensics & Forensic Pathology, Cancer Therapy and Biomarker, Epigenetic Diseases and Clinical Applications, Anatomical Pathology, Gastrointestinal Pathology & Infections, Hematopathology, Epidemiology, Epigenetics and Biomarker , Biochemistry and Molecular Biology.

The conference was greeted by the moderator Yohannes Negesse, Centre Hospitalier Universitaire de la Guadeloupe, France.  The support was extended by the Keynote Speakers Jalil Hariri, South Jutland Hospital, Denmark. Saied Ali Barzanian, Stanford University, USA and Grigorios Leon, Hellenic Society of Forensic Medicine, Greece energized by Keynote presentations:

  • The feasibility of the cervical HPV screening method as a model for a public oropharyngeal HPV screening by Jalil Hariri, South Jutland Hospital, Denmark.
  • Tech trends shaping the future of medicine, epigenetics and Epitranscriptomics by Saied Ali Barzanian, Stanford University, USA.
  • The importance of the autopsy in lethal cases of medical malpractice by Grigorios Leon Hellenic Society of Forensic Medicine, Greece

Conference Series LLC acknowledges the support of below Chairs and Co-chairs with whom we were able to run the scientific sessions smoothly. The Day-1 sessions are chaired with Jalil Hariri, Southern Jutland Hospital, Denmark.

This International Epigenetics and Epitranscriptomics Conference uplifted with more than 20 oral presentations by researchers, scientists, professors, young researchers around the globe. Conference Series LLC has taken the privilege of felicitating Epigenetics and Epitranscriptomics Organizing Committee Members and Keynote Speakers who supported for the success of this event.

With the enormous feedback from the participants and supporters of Epitranscriptomics 2018 Conference Series, Conference Series LLC is glad to announce its 2nd International Conference on Epigenetics and Epitranscriptomics is going to held during November 18-19, 2019, Helsinki, Finland.



Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 28-29, 2019

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Journal of Genetic Syndromes & Gene Therapy Journal of Stem Cell Research & Therapy Journal of Cell Science & Therapy Hereditary Genetics: Current Research

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


  • Animal Cloning Epigenetics
  • Biomarkers
  • Cancer Epigenetics
  • Cancer Stem Cell
  • Carcinogen Evaluation
  • Carcinogenesis
  • Cardiomyopathy
  • Chiasma
  • Chip Sequencing
  • Chromatin
  • Chromatin Architecture
  • Clinical Epigenetics
  • Crop Epigenetics
  • Cytogenetics
  • Developmental Epigenetics
  • DNA Footprinting
  • DNA Methylation
  • DNA Repair
  • DNA Replication
  • DNA-associated Proteins
  • Drug Toxicity
  • Ecological Epigenetics
  • Epi-drugs
  • Epigenetic Aging
  • Epigenetic Gene Regulation
  • Epigenetics
  • Epigenetics Inhibitors
  • Epigenetics Inhibitors
  • Epigenome
  • Epitranscriptomics
  • Gene Expression
  • Gene Mapping
  • Gene Ontology
  • Gene Pool
  • Gene Therapy
  • Genetic Recombination
  • Genetic Testing
  • Genetic Variation
  • Heredity
  • Histone Modification
  • Human Genetics
  • Human Imprinting Disorders
  • Human Infectious Diseases
  • Human Tumors
  • Hybridization
  • Hybridization And Heterosis
  • Hypertension
  • Immune Diseases
  • Messenger RNA
  • Molecular Biomarkers
  • MRNA Alteration
  • MRNA Capping
  • Mutagenesis
  • Neurocognitive Disorders.
  • Neurodevelopmental Disorders
  • Obesity
  • Ovarian Cancer
  • Pharmacokinetics
  • Phenotypic Variation
  • Psuedourylation
  • Psychiatric Disorders
  • Pulmonary Heart Disease
  • Replication
  • Rheumatic Heart Disease
  • Ribosomal RNA
  • RNA Modifications
  • RNA Post-Transcriptional Modifications
  • RNA Splicing
  • RNAediting
  • Single-cell Epigenetics
  • Small Nuclear RNA
  • SnRNAs
  • Stem Cells
  • Toxicology
  • Transcription
  • Transcriptome
  • Transfer RNA
  • Translational Epigenetics